Universe Pharmaceuticals Inc (UPC): Total Assets

Annual figures by period end, from SEC filings.

Figures out of scale. In this company's filings, reported revenue for the year ended 2023-09-30 is more than 100 times total assets. That usually means a value was tagged in the wrong unit. Figures are shown as filed; growth rates are not computed, and the company is left out of screens and comparisons.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2023-09-30 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$69.30B
As of 2025-09-30. As filed; likely tagged in the wrong unit
2020-09-30: $28.80M2021-09-30: $70.14M2022-09-30: $59.54M2023-09-30: $41.72M2024-09-30: $67.95B2025-09-30: $69.30B$69.30B
2020-09-30 Total Assets (USD) 2025-09-30
Period endedTotal AssetsChange YoYSource filing
2025-09-30$69.30Bn/a2026-01-29, Balance as of period end
2024-09-30$67.95Bn/a2026-01-29, Balance as of period end
2023-09-30$41.72Mn/a2025-04-29, Balance as of period end
2022-09-30$59.54Mn/a2024-01-30, Balance as of period end
2021-09-30$70.14Mn/a2023-02-10, Balance as of period end
2020-09-30$28.80Mn/a2022-01-31, Balance as of period end